April 30, 2016 11:40 AM ET


Company Overview of Aarden Pharmaceuticals, Inc.

Company Overview

Aarden Pharmaceuticals, Inc. operates as a small molecule drug discovery and development company. It develops drugs targeting the phosphatase family of proteins with emphasis on protein tyrosine phosphatases that catalyze the removal of phosphate groups from tyrosine residues of proteins and play key roles along with the tyrosine kinases in various signal transduction pathways. The company’s drug programs focus on infectious diseases, cancer, metabolic, and autoimmune therapeutic areas. Aarden Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Indianapolis, Indiana.

351 West 10th Street

Suite 248

Indianapolis, IN 46202

United States

Founded in 2008





Key Executives for Aarden Pharmaceuticals, Inc.

Chief Executive Officer, President and Director
Co-Founder and Director
Co-Founder and Director
Co-Founder and Director
Chief Scientific Officer
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
GW Group United States
Copharos, Inc. United States
PharmTak Inc. United States
Elite Laboratories, Inc. United States
X-Rx, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aarden Pharmaceuticals, Inc., please visit www.aardenpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.